Research Developments and Therapy Advancements in B-Cell Malignancies
Research Developments and Therapy Advancements in B-Cell Malignancies
B-cell lymphomas are among the leading causes of death among patients with any type of blood disorder. Our understanding of treatment options, prognostic indicators, and value in B-cell lymphomas is constantly evolving. Over the past 6 months, the treatment landscape for B-cell lymphoma has changed significantly. This slideshow highlights some of the most significant breakthroughs in such diseases.